The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions
Pierce, J., Farkas, A., and Evans, N. (1993). Tobacco use in California 1992: A focus on preventing uptake in adolescents. Sacramento: California Department of Human Services.
Plessinger, M.A. (1998). Prenatal exposure to amphetamines: Risks and adverse outcomes in pregnancy. Obstetrics and Gynecology Clinics of North America,25, 119-138.
Price, J.H., Yingling, F., Dake, J.A., and Telljohann, S.K. (2003). Adolescent smoking cessation services of school-based health centers. Health Education and Behavior,30(2), 196-208.
Proksch, J.W., Gentry, W.B., and Owens, S.M. (2000). Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats. Journal of Pharmacology and Experimental Therapeutics,292(3), 831-837.
Rawson, R.A., McCann, M.J., Hasson, A.J., and Ling, W. (2000). Addiction pharmacotherapy 2000: New options, new challenges. Journal of Psychoactive Drugs,32, 371-378.
Ridgely, M.S., Iguchi, M.Y., and Chiesa, J. (2004). The use of immunotherapies and sustained-release formulations in the treatment of drug addiction: Will current law support coercion? In H.J. Harwood and T.G. Myers (Eds.), New treatments for addiction: Behavioral, ethical, legal, and social questions. National Research Council and Institute of Medicine. Washington, DC: The National Academies Press.
Robinson, T.E., and Berridge, K.C. (2000). The psychology and neurobiology of addiction: An incentive-sensitization view. Addiction,95(Suppl 2), S91-S118.
Sagberg, F., Fosser, S., and Saetermo, I.A. (1997). An investigation of behavioural adaptation to airbags and antilock brakes among taxi drivers. Accident, Analysis and Prevention,29(3), 293-302.
Sargent, J.D., Mott, L.A., and Stevens, M. (1998). Predictors of smoking cessation in adolescents. Archives of Pediatrics and Adolescent Medicine,152(4), 388-393.
Shimm, D.S., and Speece, R.G. (1992). Rate of refusal to participate in clinical trials. IRB: A Review of Human Subjects Research,14, 7-9.
Shoeman D., Keyler, D.E., and Pentel, P. (2002). Vaccination of female rats against nicotine reduces nicotine distribution to fetal brain (abstract). Paper presented at the Society for Research on Nicotine and Tobacco Annual Meeting, Savannah, GA.
Sieber, J.E. (1994). Ethical considerations in planning and conducting research on human subjects. Academic Medicine,68(Suppl 9), 9-13.
Simister, N.E., and Story, C.M. (1997). Human placental Fc receptors and the transmission of antibodies from mother to fetus. Journal of Reproductive Immunology,37, 1-23.
Simoes, E.A., and Groothuis, J.R. (2002). Respiratory syncytial virus prophylaxis—the story so far. Respiratory Medicine,96(Suppl B), S15-S24.
Smith, M.D. (1996). Antibody production in plants. Biotechnology Advances,14(3), 267-281.
Sobeck, J., Abbey, A., Agius, E., Clinton, M., and Harrison, K. (2000). Predicting early adolescent substance use: Do risk factors differ depending on age of onset? Journal of Substance Abuse,11(1), 89-102.
Stein, M.D., and Friedman, P.D. (2001). Generalist physicians and addiction care: From turfing to sharing the turf. Journal of the American Medical Association,286, 1764-1765.
Sturm, R., Goldman, W., and McCulloch, J. (1998). Mental health and substance abuse parity: A study of Ohio’s state employee program. Journal of Mental Health Policy and Economics,1(3), 129-134.
Substance Abuse and Mental Health Services Administration. (2002). National Survey of Substance Abuse Treatment Services (N-SSATS): 2000 data on substance abuse treatment facilities. (Rep. No. DASIS Series: A-16; DHHS Publication No. SMA 02-3668). Rockville, MD: Author.